PT - JOURNAL ARTICLE AU - Fazel-Najafabadi, Mehdi AU - Looger, Loren L. AU - Reddy-Rallabandi, Harikrishna AU - Nath, Swapan K. TI - A multilayered post-GWAS analysis pipeline defines functional variants and target genes for systemic lupus erythematosus (SLE) AID - 10.1101/2023.04.07.23288295 DP - 2023 Jan 01 TA - medRxiv PG - 2023.04.07.23288295 4099 - http://medrxiv.org/content/early/2023/09/29/2023.04.07.23288295.short 4100 - http://medrxiv.org/content/early/2023/09/29/2023.04.07.23288295.full AB - Objectives Systemic lupus erythematosus (SLE), an autoimmune disease with incompletely understood etiology, has a strong genetic component. Although genome-wide association studies (GWAS) have revealed multiple SLE susceptibility loci and associated single nucleotide polymorphisms (SNPs), the precise causal variants, target genes, cell types, tissues, and mechanisms of action remain largely unknown.Methods Here, we report a comprehensive post-GWAS analysis using extensive bioinformatics, molecular modeling, and integrative functional genomic and epigenomic analyses to optimize fine-mapping. We compile and cross-reference immune cell-specific expression quantitative trait loci (cis- and trans-eQTLs) with promoter-capture Hi-C, allele-specific chromatin accessibility, and massively parallel reporter assay data to define predisposing variants and target genes. We experimentally validate a predicted locus using CRISPR/Cas9 genome editing, qPCR, and Western blot.Results Anchoring on 452 index SNPs, we selected 9,931 high-linkage disequilibrium (r2>0.8) SNPs and defined 182 independent non-HLA SLE loci. 3,746 SNPs from 143 loci were identified as regulating 564 unique genes. Target genes are enriched in lupus-related tissues and associated with other autoimmune diseases. Of these, 329 SNPs (106 loci) showed significant allele-specific chromatin accessibility and/or enhancer activity, indicating regulatory potential. Using CRISPR/Cas9, we validated rs57668933 as a functional variant regulating multiple targets, including SLE risk gene ELF1, in B-cells.Conclusion We demonstrate and validate post-GWAS strategies for utilizing multi-dimensional data to prioritize likely causal variants with cognate gene targets underlying SLE pathogenesis. Our results provide a catalog of significantly SLE-associated SNPs and loci, target genes, and likely biochemical mechanisms, to guide experimental characterization.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by National Institutes of Health grants R01AI172255 and R21AI168943 (SKN).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves various genomic data downloaded from public databases (1000Genomes data, various chromatin marks from ENCODE, and Summary GWAS), and cell lines bought from ATCC. This project was approved by Institutional Review Board, OMRF.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors